PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
August 6, 2026Journal of Case Reports and Images in OncologyOpen Access

Complete remission of metastatic mismatch repairdeficient/microsatellite instability-high esophageal adenocarcinoma following immunotherapy: A case report

View Full Paper
Ask AI
Bookmark
Share

Authors

ELEric Ka Chai LEESLSuat LooAJAparna Juneja

Discussion

Loading...

Member takes

Overview

Case report shows complete remission of advanced cancer using immunotherapy, suggesting new treatment potential.

Key Points

  • To describe the effects of immunotherapy on a patient with metastatic mismatch repair deficient esophageal adenocarcinoma.
  • Immunotherapy treatment was administered to a patient with metastatic disease.
  • Patient's response to treatment was monitored over time for signs of remission.
  • Patient achieved complete remission of metastatic cancer following immunotherapy.
  • No recurrence of disease has been reported at follow-up.

Cite This Study

LEE et al. (2026) studied this question.

synapsesocial.com/papers/6a743773764cddc9499d4c98https://doi.org/10.5348/100158z10el2026ci
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global cancer statistics, 20122015 · 27,417 citations
  2. 2Mismatch Repair Deficiency, Microsatellite Instability, and Survival2017 · 536 citations
  3. 3KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer2018 · 24 citations
  4. 4Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer2018 · 1,830 citations
  5. 5Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer2019 · 494 citations